Related Experiment Video
Updated: Aug 21, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Differential expression of TKS4 isoforms and their role in cellular processes in breast cancer
Serhii Kropyvko1, Nazar Shevchuk1, Olga Gubar1
1Department of Functional Genomics Institute of Molecular Biology and Genetics NAS of Ukraine Kyiv Ukraine.
Abstract:
The scaffold protein TKS4 plays a role in the development of several cancers. Alternative splicing of the TKS4 gene generates two isoforms, TKS4L and TKS4b; however, their distinct expression patterns and functional roles have not yet been characterized. We have shown that TKS4 isoforms were differentially expressed across human cell lines and breast cancer (BC) tumor samples. Both TKS4L and TKS4L/TKS4b mRNA ratios were significantly altered in tumors compared with adjacent tissues. We identified six novel binding SRC homology 3-domain-containing partners for TKS4L, none of which interact with TKS4b, suggesting their functional differences. Tyrosine phosphorylation of both isoforms was induced by Src(Y527F) kinase overexpression, enabling binding to the SH2 domains of signaling proteins. Interestingly, TKS4b significantly accumulated in the nucleus, whereas TKS4L was primarily present in the cytosol in MCF-7 cells. TKS4b overexpression enhanced MCF-7 cell migration. Both TKS4 isoforms exhibit oncogenic properties by promoting epithelial-mesenchymal transition in BC cells, highlighting their potential as targets for therapeutic intervention.
Insights
The scaffold protein TKS4, crucial in cancer, has two isoforms, TKS4L and TKS4b, with distinct functions. Both promote cancer progression by driving epithelial-mesenchymal transition, suggesting TKS4 as a therapeutic target.
Area of Science:
- Molecular biology
- Cancer research
- Cell biology
Background:
- The scaffold protein TKS4 is implicated in cancer development.
- Alternative splicing of the TKS4 gene produces TKS4L and TKS4b isoforms.
- The distinct expression and functions of TKS4 isoforms are not well understood.
Purpose of the Study:
- To investigate the differential expression and functional roles of TKS4L and TKS4b isoforms in breast cancer.
- To identify binding partners and signaling interactions of TKS4 isoforms.
- To explore the impact of TKS4 isoforms on cancer cell behavior.
Main Methods:
- Differential expression analysis of TKS4 isoforms in cell lines and breast cancer tissues.
- Identification of TKS4 isoform binding partners using biochemical assays.
- Analysis of TKS4 isoform localization and tyrosine phosphorylation.
- Assessment of TKS4 isoform effects on cell migration and epithelial-mesenchymal transition.
Main Results:
- TKS4 isoforms show differential expression in breast cancer cells and tumors.
- TKS4L binds to novel SRC homology 3-domain-containing partners, distinct from TKS4b.
- TKS4b localizes to the nucleus, while TKS4L is primarily in the cytosol.
- Both isoforms promote epithelial-mesenchymal transition and TKS4b enhances cell migration.
Conclusions:
- TKS4L and TKS4b possess distinct cellular localizations and binding interactions, indicating functional divergence.
- Both TKS4 isoforms contribute to breast cancer progression through oncogenic properties.
- TKS4 isoforms represent potential therapeutic targets for breast cancer intervention.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...